Novo Nordisk s.r.o.

Novo Nordisk s.r.o. is the Czech Republic subsidiary of Novo Nordisk A/S, the Danish multinational pharmaceutical company. It operates as a local sales and marketing affiliate, distributing Novo Nordisk's prescription medicines in the Czech market. The Czech website presents the company's heritage, career opportunities, and business ethics framework, and states that all Novo Nordisk medicines available in the Czech Republic are prescription-only and must be dispensed through authorised distributors and pharmacies. The affiliate does not promote prescription medicines to the general public, in line with Czech law. Its product portfolio reflects the parent company's global focus on diabetes care, obesity, and other serious chronic diseases, including protein-based therapies. The Czech entity is registered as a business in the Czech Republic and is part of the Novo Nordisk group, whose history dates back to two Danish companies founded in the 1920s.

Novo Nordisk s.r.o. is the Czech affiliate of Novo Nordisk A/S. The parent company's history began in 1923 when two Danish firms, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium, started insulin production in Scandinavia. The Czech subsidiary carries this heritage into the local market, where it distributes Novo Nordisk's prescription medicines. The Czech website outlines the company's century-long history, from the first insulin treatments in Denmark to modern protein-based therapies for serious chronic diseases. As a local sales and marketing organisation, Novo Nordisk s.r.o. handles regulatory compliance, medical information, and distribution through authorised channels in the Czech Republic. It emphasises ethical business practices, including adherence to anti-corruption laws and transparency in interactions with healthcare professionals and patient organisations. The affiliate does not promote prescription medicines to the public and ensures that all products are available only by prescription through licensed pharmacies.

• 1923

  Parent company's predecessor firms begin insulin production in Scandinavia

• 1923

  First patients treated with insulin in Denmark

Local affiliate of a global pharmaceutical leader, focused on prescription medicines and ethical business conduct in the Czech market.

Product categories. Prescription medicines for diabetes · Protein-based therapies for chronic diseases

1. 1Novo Nordisk Česká republika – oficiální stránkynovonordisk.cz
2. 2Naše dědictví | Novo Nordisknovonordisk.cz
3. 3Etika podnikání | Novo Nordisknovonordisk.cz
4. 4Novo Nordisk s.r.o. – Wikidatawikidata.org